Béatrice Clémenceau Selected Research

Immunotherapy

1/2017	Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
1/2014	The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.
9/2007	Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Béatrice Clémenceau Research Topics

Disease

9	Neoplasms (Cancer) 10/2021 - 09/2007
2	Breast Neoplasms (Breast Cancer) 04/2015 - 01/2006
2	Infections 12/2010 - 01/2005
1	Multiple Myeloma 06/2021
1	COVID-19 03/2021
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Autoimmune Hepatitis 12/2020
1	Merkel Cell Carcinoma 08/2018
1	Neuralgia (Stump Neuralgia) 01/2017
1	Lipoma (Lipomata) 04/2015
1	Lymphoma (Lymphomas) 04/2014
1	Ovarian Neoplasms (Ovarian Cancer) 01/2014
1	Ovarian Epithelial Carcinoma 01/2014
1	Granulosa Cell Tumor 01/2014
1	Adenocarcinoma 01/2006

Drug/Important Bio-Agent (IBA)

6	Monoclonal AntibodiesIBA 01/2017 - 01/2006
4	AntigensIBA 10/2021 - 09/2007
3	Trastuzumab (Herceptin)FDA Link 04/2015 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 07/2014
2	Rituximab (Mabthera)FDA Link 07/2014 - 01/2006
1	Chimeric Antigen ReceptorsIBA 10/2021
1	daratumumabIBA 06/2021
1	GlycosyltransferasesIBA 03/2021
1	ABO Blood-Group SystemIBA 03/2021
1	AntibodiesIBA 03/2021
1	EpitopesIBA 03/2021
1	Blood Group Antigens (Blood Groups)IBA 03/2021
1	Polysaccharides (Glycans)IBA 03/2021
1	liver antigen LA-1IBA 12/2020
1	AutoantibodiesIBA 12/2020
1	Surface Antigens (Surface Antigen)IBA 08/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2018
1	dinutuximabIBA 01/2017
1	GangliosidesIBA 01/2017
1	GlycolipidsIBA 01/2017
1	O-acetyl-GD2 gangliosideIBA 01/2017
1	Conditioned Culture MediaIBA 04/2015
1	human ERBB2 proteinIBA 04/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Biological ProductsIBA 07/2014
1	Immunoglobulin G (IgG)IBA 07/2014
1	InterleukinsIBA 07/2014
1	CytokinesIBA 07/2014
1	CD20 AntigensIBA 07/2014
1	Interleukin-15 (Interleukin 15)IBA 07/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2014
1	A-Form DNA (A-DNA)IBA 12/2010
1	Complement System Proteins (Complement)IBA 09/2007
1	GD2 gangliosideIBA 09/2007
1	Interleukin-2 (IL2)IBA 01/2006

Therapy/Procedure

4	Therapeutics 04/2015 - 01/2014
3	Immunotherapy 01/2017 - 09/2007
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021
1	Drug Therapy (Chemotherapy) 01/2006
1	Islets of Langerhans Transplantation 01/2005
1	Heterologous Transplantation (Xenotransplantation) 01/2005